SAN JOSE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the ...
In celebration of National Cancer Prevention Day, Anpac Bio has announced that their cancer differentiation analysis (CDA) liquid biopsy test is now capable of detecting 26 different cancers from a ...
AnPac Bio-Medical Science Co., Ltd. ANPC was founded in 2010 by an inventor in the semiconductor technology industry and an expert in molecular epidemiology and cancer research. The two visionaries ...
Radiomics features of ground glass nodules tailored different pathological grades of lung adenocarcinoma. Details of CDA statistical analysis results.
NEW YORK, Feb. 22, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a company with operations in the United States and China focused on early ...
PHILADELPHIA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback